相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Biologic treatments for adult-onset Still's disease
Ibrahim A. Al-Homood
RHEUMATOLOGY (2014)
Effectiveness of First-Line Treatment With Recombinant Interleukin-1 Receptor Antagonist in Steroid-Naive Patients With New-Onset Systemic Juvenile Idiopathic Arthritis Results of a Prospective Cohort Study
Sebastiaan J. Vastert et al.
ARTHRITIS & RHEUMATOLOGY (2014)
Long-Term Safety and Efficacy of Rilonacept in Patients With Systemic Juvenile Idiopathic Arthritis
Daniel J. Lovell et al.
ARTHRITIS AND RHEUMATISM (2013)
2013 Update of the 2011 American College of Rheumatology Recommendations for the Treatment of Juvenile Idiopathic Arthritis Recommendations for the Medical Therapy of Children With Systemic Juvenile Idiopathic Arthritis and Tuberculosis Screening Among Children Receiving Biologic Medications
Sarah Ringold et al.
ARTHRITIS AND RHEUMATISM (2013)
Distinct subsets of patients with systemic juvenile idiopathic arthritis based on their cytokine profiles
Masaki Shimizu et al.
CYTOKINE (2013)
T helper 17 polarization in familial Mediterranean fever
A. Ovadia et al.
GENES AND IMMUNITY (2013)
Patients with Very Early-onset Systemic Juvenile Idiopathic Arthritis Exhibit More Inflammatory Features and a Worse Outcome
Ricardo A. G. Russo et al.
JOURNAL OF RHEUMATOLOGY (2013)
PReS-FINAL-2157: Efficacy of canakinumab in the treatment of systemic juvenile idiopathic arthritis: a 12-week pooled post-hoc analysis
P Quartier et al.
Pediatric Rheumatology (2013)
The plasticity of human Treg and Th17 cells and its role in autoimmunity
Markus Kleinewietfeld et al.
SEMINARS IN IMMUNOLOGY (2013)
Pulmonary Hypertension and Other Potentially Fatal Pulmonary Complications in Systemic Juvenile Idiopathic Arthritis
Yukiko Kimura et al.
ARTHRITIS CARE & RESEARCH (2013)
Anakinra pharmacokinetics in children and adolescents with systemic-onset juvenile idiopathic arthritis and autoinflammatory syndromes
Saik Urien et al.
BMC PHARMACOLOGY & TOXICOLOGY (2013)
A phase II, multicenter, open-label study evaluating dosing and preliminary safety and efficacy of canakinumab in systemic juvenile idiopathic arthritis with active systemic features
Nicolino Ruperto et al.
ARTHRITIS AND RHEUMATISM (2012)
Rates of hospitalized bacterial infection associated with juvenile idiopathic arthritis and its treatment
Timothy Beukelman et al.
ARTHRITIS AND RHEUMATISM (2012)
Sustained response and prevention of damage progression in patients with neonatal-onset multisystem inflammatory disease treated with anakinra: A cohort study to determine three- and five-year outcomes
Cailin H. Sibley et al.
ARTHRITIS AND RHEUMATISM (2012)
Alternative activation in systemic juvenile idiopathic arthritis monocytes
Claudia Macaubas et al.
CLINICAL IMMUNOLOGY (2012)
Successful treatment of adult-onset Still's disease with tocilizumab monotherapy: two case reports and literature review
Ryota Sakai et al.
CLINICAL RHEUMATOLOGY (2012)
Pathogen-induced human TH17 cells produce IFN-γ or IL-10 and are regulated by IL-1β
Christina E. Zielinski et al.
NATURE (2012)
Two Randomized Trials of Canakinumab in Systemic Juvenile Idiopathic Arthritis
Nicolino Ruperto et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Randomized Trial of Tocilizumab in Systemic Juvenile Idiopathic Arthritis
Fabrizio De Benedetti et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Making Sense of the Cytokine Storm: A Conceptual Framework for Understanding, Diagnosing, and Treating Hemophagocytic Syndromes
Scott W. Canna et al.
PEDIATRIC CLINICS OF NORTH AMERICA (2012)
Th1 and Th17 cell subpopulations are enriched in the peripheral blood of patients with systemic juvenile idiopathic arthritis
Ebun Omoyinmi et al.
RHEUMATOLOGY (2012)
Anakinra: A safe and effective first-line treatment in systemic onset juvenile idiopathic arthritis (SoJIA)
C. M. Hedrich et al.
RHEUMATOLOGY INTERNATIONAL (2012)
A multicentre, randomised, double-blind, placebo-controlled trial with the interleukin-1 receptor antagonist anakinra in patients with systemic-onset juvenile idiopathic arthritis (ANAJIS trial)
Pierre Quartier et al.
ANNALS OF THE RHEUMATIC DISEASES (2011)
Anakinra as First-Line Disease-Modifying Therapy in Systemic Juvenile Idiopathic Arthritis Report of Forty-Six Patients From an International Multicenter Series
Peter A. Nigrovic et al.
ARTHRITIS AND RHEUMATISM (2011)
Interleukin-1 in the pathogenesis and treatment of inflammatory diseases
Charles A. Dinarello
BLOOD (2011)
Combination Therapy of Abatacept and Anakinra in Children with Refractory Systemic Juvenile Idiopathic Arthritis: A Retrospective Case Series
Jessica L. Record et al.
JOURNAL OF RHEUMATOLOGY (2011)
Pathogenesis of systemic juvenile idiopathic arthritis: some answers, more questions
Elizabeth D. Mellins et al.
NATURE REVIEWS RHEUMATOLOGY (2011)
Role of IL-1 Beta in the Development of Human TH17 Cells: Lesson from NLPR3 Mutated Patients
Denise Lasiglie et al.
PLOS ONE (2011)
Excessive Interleukin-1 Signaling Determines the Development of Th1 and Th17 Responses in Chronic Inflammation
Leo A. B. Joosten
ARTHRITIS AND RHEUMATISM (2010)
Monocytes are resistant to apoptosis in systemic juvenile idiopathic arthritis
Shivani Srivastava et al.
CLINICAL IMMUNOLOGY (2010)
Interleukin-1β and Interleukin-6 in Arthritis Animal Models: Roles in the Early Phase of Transition from Acute to Chronic Inflammation and Relevance for Human Rheumatoid Arthritis
Gianfranco Ferraccioli et al.
MOLECULAR MEDICINE (2010)
IL-1 pathways in inflammation and human diseases
Cem Gabay et al.
NATURE REVIEWS RHEUMATOLOGY (2010)
Mutations in the perforin gene can be linked to macrophage activation syndrome in patients with systemic onset juvenile idiopathic arthritis
Sebastiaan J. Vastert et al.
RHEUMATOLOGY (2010)
Early Outcomes and Improvement of Patients With Juvenile Idiopathic Arthritis Enrolled in a Canadian Multicenter Inception Cohort
Kiem Oen et al.
ARTHRITIS CARE & RESEARCH (2010)
Anakinra in the treatment of polyarticular-course juvenile rheumatoid arthritis: safety and preliminary efficacy results of a randomized multicenter study
Norman Ilowite et al.
CLINICAL RHEUMATOLOGY (2009)
Adult Outcomes of Patients with Juvenile Idiopathic Arthritis
Kirsten Minden
HORMONE RESEARCH (2009)
Anakinra for Systemic Juvenile Arthritis The Rocky Mountain Experience
Andrew Zeft et al.
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY (2009)
An Autoinflammatory Disease with Deficiency of the Interleukin-1-Receptor Antagonist
Ivona Aksentijevich et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Mutations of the hemophagocytic lymphohistiocytosis-associated gene UNC13D in a patient with systemic juvenile idiopathic arthritis
Melissa M. Hazen et al.
ARTHRITIS AND RHEUMATISM (2008)
Interleukin-1 Drives Pathogenic Th17 Cells During Spontaneous Arthritis in Interleukin-1 Receptor Antagonist-Deficient Mice
Marije I. Koenders et al.
ARTHRITIS AND RHEUMATISM (2008)
The pattern of response to anti-interleukin-1 treatment distinguishes two subsets of patients with systemic-onset juvenile idiopathic arthritis
Marco Gattorno et al.
ARTHRITIS AND RHEUMATISM (2008)
Efficacy and safety of tocilizumab in patients with systemic-onset juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled, withdrawal phase III trial
Shumpei Yokota et al.
LANCET (2008)
Interleukin-1 receptor antagonist (anakinra) treatment in patients with systemic-onset juvenile idiopathic arthritis or adult onset Still disease:: preliminary experience in France
T. Lequerre et al.
ANNALS OF THE RHEUMATIC DISEASES (2008)
Specific gene expression profiles in systemic juvenile idiopathic arthritis
Emma Mary Ogilvie et al.
ARTHRITIS AND RHEUMATISM (2007)
Mast cells contribute to initiation of autoantibody-mediated arthritis via IL-1
Peter A. Nigrovic et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
T cell self-reactivity forms a cytokine milieu for spontaneous development of IL-17+ Th cells that cause autoimmune arthritis
Keiji Hirota et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
Neonatal-onset multisystem inflammatory disease responsive to interleukin-1β inhibition
Raphaela Goldbach-Mansky et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Predictors of disease course and remission in systemic juvenile idiopathic arthritis - Significance of early clinical and laboratory features
D. Singh-Grewal et al.
ARTHRITIS AND RHEUMATISM (2006)
Care of the adult with juvenile rheumatoid arthritis
PA Nigrovic et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2006)
Autologous stem cell transplantation for autoimmunity induces immunologic self-tolerance by reprogramming autoreactive T cells and restoring the CD4+CD25+ immune regulatory network
I de Kleer et al.
BLOOD (2006)
CD28-dependent differentiation into the effector/memory phenotype is essential for induction of arthritis in interleukin-1 receptor antagonist-deficient mice
M Kotani et al.
ARTHRITIS AND RHEUMATISM (2006)
Role of interleukin-1 (IL-1) in the pathogenesis of systemic onset juvenile idiopathic arthritis and clinical response to IL-1 blockade
V Pascual et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Natural killer cell dysfunction is a distinguishing feature of systemic onset juvenile rheumatoid arthritis and macrophage activation syndrome
J Villanueva et al.
ARTHRITIS RESEARCH & THERAPY (2005)
Distinct contribution of IL-6, TNF-α, IL-1, and IL-10 to T cell-mediated spontaneous autoimmune arthritis in mice
H Hata et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
Altered thymic T-cell selection due to a mutation of the ZAP-70 gene causes autoimmune arthritis in mice
N Sakaguchi et al.
NATURE (2003)
IL-17 production from activated T cells is required for the spontaneous development of destructive arthritis in mice deficient in IL-1 receptor antagonist
S Nakae et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Natural killer cell dysfunction in patients with systemic-onset juvenile rheumatoid arthritis and macrophage activation syndrome
AA Grom et al.
JOURNAL OF PEDIATRICS (2003)
Reduced perforin expression in systemic juvenile idiopathic arthritis is restored by autologous stem-cell transplantation
NM Wulffraat et al.
RHEUMATOLOGY (2003)
The-174G allele of the interleukin-6 gene confers susceptibility to systemic arthritis in children - A multicenter study using simplex and multiplex juvenile idiopathic arthritis families
EM Ogilvie et al.
ARTHRITIS AND RHEUMATISM (2003)
Juvenile idiopathic arthritis classified by the ILAR criteria: HLA associations in UK patients
W Thomson et al.
RHEUMATOLOGY (2002)
The importance of IL-1β and TNF-α, and the noninvolvement of IL-6, in the development of monoclonal antibody-induced arthritis
T Kagari et al.
JOURNAL OF IMMUNOLOGY (2002)
Critical roles for interleukin 1 and tumor necrosis factor at in antibody-induced arthritis
H Ji et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2002)
Suppression of autoimmune arthritis in interleukin-1-deficient mice in which T cell activation is impaired due to low levels of CD40 ligand and OX40 expression on T cells
S Saijo et al.
ARTHRITIS AND RHEUMATISM (2002)
The genetic and immunopathological processes underlying collagen-induced arthritis
JA Luross et al.
IMMUNOLOGY (2001)
Development of chronic inflammatory arthropathy resembling rheumatoid arthritis in interleukin 1 receptor antagonist-deficient mice
R Horai et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2000)
分享论文
